Overview

Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Topical steroid use may lead to skin deterioration and spider veins. This study will examine long-term management of atopic dermatitis (AD) over 12 months with pimecrolimus cream 1% and its effect on skin reconstitution of steroid-damaged skin and disease control.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Pimecrolimus
Tacrolimus